CardioGenics Holdings Inc (CGNH)
-OTC Markets 0.35 0.00(0.00%) May 21, 3:54PM EDT
| Prev Close: | 0.35 |
|---|
| Open: | 0.32 |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 2.00 |
|---|
| Beta: | 0.93 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 0.29 - 0.35 |
|---|
| 52wk Range: | 0.11 - 0.50 |
|---|
| Volume: | 12,019 |
|---|
| Avg Vol (3m): | 17,411 |
|---|
| Market Cap: | 19.84M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.02 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- CARDIOGENICS HOLDINGS INC. FinancialsEDGAR Online Financials(Fri, Mar 22)
- CARDIOGENICS HOLDINGS INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online(Mon, Mar 18)
- CARDIOGENICS HOLDINGS INC. Files SEC form 10-K, Annual ReportEDGAR Online(Tue, Jan 29)
- CARDIOGENICS HOLDINGS INC. Files SEC form 8-K, Financial Statements and ExhibitsEDGAR Online(Fri, Jan 18)
- CARDIOGENICS HOLDINGS INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online(Fri, Sep 14)
- CARDIOGENICS HOLDINGS INC. Files SEC form 10-K/A, Annual ReportEDGAR Online(Mon, Apr 16)
- CARDIOGENICS HOLDINGS INC. Files SEC form 10-K/A, Annual ReportEDGAR Online(Mon, Apr 16)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 123,208.69 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Oct-11)
: | N/A |
|---|
| Quarterly EPS Est
(Jul-11)
: | N/A |
|---|
| Mean Recommendation*: | 2.0 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
CardioGenics Holdings Inc., a development stage company, engages in the development and commercialization of diagnostic test products for the immunoassay segment of the in vitro diagnostics testing market in the United States, Canada, and Europe.
View More 
0.34%